Abstract
Metformin is a widely described drug in treatment and prevention of type 2 diabetes. Although its mechanism of action is not well understood, new evidence supports that metformin could affect thyroid profile in patients with type 2 diabetes. Aim of this study was to access the effect of metformin treatment on thyroid axis hormones in diabetic patients with normal thyroid function. Thus, one hundred eight euthyroid subjects were selected for being healthy controls, obese insulin resistant not treated with metformin, and diabetic non-obese or diabetic obese treated with metformin. Circulating hormones were determined by ELISA. Our data show that thyroid function parameters were not significantly different in diabetic subjects treated with metformin compared to healthy controls. However, diabetics showed significantly lower thyrotropin levels than those of obese insulin resistant subjects untreated with metformin. Further, no significant change in free T4 was observed. In conclusions metformin administration may affect thyroid axis in type 2 diabetic patients. Interestingly, it seems to bring some benefits by maintaining plasma thyrotropin levels to subnormal levels in diabetics. However, more investigations are needed to elucidate the exact mechanism at a cellular and molecular level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
